Garlic Supplement Dissolution Standards Clinical Trial Use Suggested
This article was originally published in The Tan Sheet
Executive Summary
Future clinical trials on garlic and cardiovascular disease should use supplements that pass U.S. Pharmacopeia dissolution standards for high allicin release, a researcher suggested at a National Institutes of Health conference June 12 in Bethesda, Md.
You may also be interested in...
Lichtwer Kwai Garlic Effects On Cholesterol "Debatable" - Meta-Analysis
Clinical studies examining the efficacy of different garlic formulations at comparable doses "would help determine whether garlic has a specific effect on cholesterol levels," researchers conclude in a meta-analysis appearing in the Sept. 19 Annals of Internal Medicine.
AHCPR Awards Garlic, Milk Thistle Studies To Univ. Of Texas Center
The effect of garlic on cardiovascular disease and cancer prevention and Silybum marianum (milk thistle) on liver disease is being investigated by the University of Texas Health Science Center, San Antonio, under a grant from HHS' Agency for Health Care Policy & Research.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC